Erratum: Thadi A.; et al. Early Investigations and Recent Advances in Intraperitoneal Immunotherapy for Peritoneal Metastasis. Vaccines 2018, 6, 54

Anusha Thadi,Marian Khalili,William F Morano,Scott D Richard,Steven C Katz,Wilbur B Bowne

DOI: https://doi.org/10.3390/vaccines7010015

2019-01-31

Abstract:The authors wish to make the following corrections to this paper [...].

What problem does this paper attempt to address?

Corrigendum to "Long recurrence-free survival of localized rectal melanoma after abdominoperineal resection in comparison to partial excision and highlighting the place of immunotherapy: A case report."

DOI: https://doi.org/10.1177/20542704241260192

2024-06-02

JRSM Open

Abstract:[This corrects the article DOI: 10.1177/20542704221148059.].
Correction To: Therapeutic Efficacy, Pharmacokinetic Profiles, and Toxicological Activities of Humanized Antibody-Drug Conjugate Zt/g4-MMAE Targeting RON Receptor Tyrosine Kinase for Cancer Therapy

Hang-Ping Yao,Liang Feng,Sreedhar Reddy Suthe,Ling-Hui Chen,Tian-Hao Weng,Chen-Yu Hu,Eun Sung Jun,Zhi-Gang Wu,Wei-Lin Wang,Song Cheol Kim,Xiang-Min Tong,Ming-Hai Wang

DOI: https://doi.org/10.1186/s40425-019-0571-7

IF: 12.469

2019-01-01

Journal for ImmunoTherapy of Cancer

Abstract:Following publication of the original article [1], the author reported two errors in the authors affiliations:
Correction To: Early Presence of Anti-Angiogenesis-related Adverse Events As a Potential Biomarker of Antitumor Efficacy in Metastatic Gastric Cancer Patients Treated with Apatinib: a Cohort Study

Xinyang Liu,Shukui Qin,Zhichao Wang,Jianming Xu,Jianping Xiong,Yuxian Bai,Zhehai Wang,Yan Yang,Guoping Sun,Liwei Wang,Leizhen Zheng,Nong Xu,Ying Cheng,Weijian Guo,Hao Yu,Tianshu Liu,Pagona Lagiou,Jin Li

DOI: https://doi.org/10.1186/s13045-017-0545-5

IF: 28.5

2017-01-01

Journal of Hematology & Oncology

Abstract:The original article [1] contains two errors in Table 2
Correction: Cao et al. Effective Functional Immunogenicity of a DNA Vaccine Combination Delivered via In Vivo Electroporation Targeting Malaria Infection and Transmission. Vaccines 2022, 10, 1134

Yi Cao,Clifford T. H. Hayashi,Fidel Zavala,Abhai K. Tripathi,Hayk Simonyan,Colin N. Young,Leor C. Clark,Yukari Usuda,Jacob M. Van Parys,Nirbhay Kumar

DOI: https://doi.org/10.3390/vaccines12090994

2024-09-03

Vaccines

Abstract:The authors would like to make the following corrections to this published paper [...]

immunology,medicine, research & experimental
Corrigendum: Surgical decision-making following neoadjuvant immunotherapy for dMMR rectal cancer; case reports and review of the literature

Mef Nilbert,Jakob Eberhard,Jenny Engdahl Severin,Marcus Edelhamre,Filip Torle,Dejan Korkocic,Fredrik Jörgren

DOI: https://doi.org/10.2340/1651-226x.2024.40158

IF: 4.311

2024-02-29

Acta Oncologica

Abstract:Corrigendum for article: DOI: 10.1080/0284186X.2023.2281005

oncology
Erratum: New insights into the role of macrophages in cancer immunotherapy

Frontiers Production Office

DOI: https://doi.org/10.3389/fimmu.2024.1427337

IF: 7.3

2024-05-17

Frontiers in Immunology

Abstract:This article is an erratum on: New insights into the role of macrophages in cancer immunotherapy

immunology
Erratum: First step results from a phase II study of a dendritic cell vaccine in glioblastoma patients (CombiG-vax)

Frontiers Production Office

DOI: https://doi.org/10.3389/fimmu.2024.1494021

2024-09-19

Abstract:[This corrects the article DOI: 10.3389/fimmu.2024.1404861.].
Erratum: The efficacy of cancer immunotherapies is compromised by Helicobacter pylori infection

DOI: https://doi.org/10.3389/fimmu.2023.1183107

IF: 7.3

2023-03-21

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.899161.].

immunology
Erratum: Preoperative immunological plasma markers TRAIL, CSF1, and TIE2 predict survival after resection for biliary tract cancer

Frontiers Production Office

DOI: https://doi.org/10.3389/fonc.2023.1281693

2023-09-27

Abstract:[This corrects the article DOI: 10.3389/fonc.2023.1169537.].
Corrigendum to: Investigation of the Apoptosis Inducing and β-catenin Silencing by Tetradentate Schiff Base Zinc(II) Complex on the T-47D Breast Cancer Cells

Mostafa Heidari Majd,Xiangyu Guo

DOI: https://doi.org/10.2174/187152062405240209150030

IF: 2.8

2024-02-01

Anti-Cancer Agents in Medicinal Chemistry

Abstract:A typographical error appeared in the author affiliation titled “Investigation of the Apoptosis Inducing and β-catenin Silencing by Tetradentate Schiff Base Zinc(II) Complex on the T-47D Breast Cancer Cells”, published in Anti-Cancer Agents in Medicinal Chemistry, 2023, 23(15) [1]. Details of the error and a correction are provided here. Original: Author Affiliation: 2Department of Breast Medicine, Cancer Hospital Chinese Academy of Medical Science, Liaoning Provincial Cancer Hospital, Shenyang, Liaoning, 110042, China Corrected: Author Affiliation: 2Department of Breast Medicine, Cancer Hospital of China Medical University, Liaoning Cancer Hospital, Shenyang, China We regret the error and apologize to readers. The original article can be found online at https://www.eurekaselect.com/article/131718

oncology,chemistry, medicinal
Erratum: "Interferon-γ liposome: a new system to improve drug delivery in the treatment of lung cancer". Maysa Alhawamdeh, Mohammad Isreb, Abid Aziz, Badie K. Jacob, Diana Anderson and Mojgan Najafzadeh. ERJ Open Res 2021; 7: 00555-2020

DOI: https://doi.org/10.1183/23120541.50555-2020

2021-12-06

Abstract:[This corrects the article DOI: 10.1183/23120541.00555-2020.].
Corrigendum: Ex vivo modulation of intact tumor fragments with anti-PD-1 and anti-CTLA-4 influences the expansion and specificity of tumor-infiltrating lymphocytes

Thomas Morgan Hulen,Christina Friese,Nikolaj Pagh Kristensen,Joachim Stoltenborg Granhøj,Troels Holz Borch,Marlies J W Peeters,Marco Donia,Mads Hald Andersen,Sine Reker Hadrup,Inge Marie Svane,Özcan Met

DOI: https://doi.org/10.3389/fimmu.2024.1462081

2024-07-18

Abstract:[This corrects the article DOI: 10.3389/fimmu.2023.1180997.].
Erratum to : Introduction to the peripheral T-cell lymphoma review series: advances in molecular characterization, classification refinement and treatment optimization

Kerry J. Savage,Laurence De Leval

DOI: https://doi.org/10.3324/haematol.2024.285005

2024-02-02

Haematologica

Abstract:After the publication of the article "Introduction to the peripheral T-cell lymphoma review series: advances in molecular characterization, classification refinement and treatment optimization" by Kerry J. Savage and Laurence de Leval in the December 2023 issue, 1 we realized that an error had been made in Table 1. The correct table is shown below. The Editorial Office apologize for the inconvenience.

hematology
Erratum to Erratum to relationships between serum levels of vitamins and papillary thyroid cancer: a single center case-control study

Editorial Office

DOI: https://doi.org/10.21037/gs-2024-1

2024-09-03

Gland Surgery

Abstract:Editorial Office Gland Surgery Submitted Apr 28, 2024. Accepted for publication Jul 18, 2024. Published online Aug 28, 2024. doi: 10.21037/gs-2024-1 Erratum to: Gland Surg 2023;12:1326-7 In the June 2023 issue of Gland Surgery , the paper titled "Erratum to relationships between serum levels of vitamins and papillary thyroid cancer: a single center case-control study" ( Gland Surg 2023;12:1326-7. doi: 10.21037/gs-2023-04) (1), was published for correction of the registration number of the ethics board in the article (2) published earlier. However, there are still some errors found in the funding information. The updated "Acknowledgments" section and "Footnote" section are presented below. In the "Acknowledgments" part, the Funding should be corrected as: Funding: The study was funded by specific grant from Istituto Auxologico Italiano. In the "Footnote" part, the Conflicts of Interest should be corrected as: Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://gs.amegroups.com/article/view/10.21037/gs-22-520/coif). The authors have no conflicts of interest to declare. In the ICMJE uniform disclosure form (available at https://gs.amegroups.com/article/view/10.21037/gs-22-520/coif), the funding information disclosed in item #1 should be corrected as: The study was funded by specific grant from Istituto Auxologico Italiano. The authors regret the error and all inconveniences caused. Click here to view the updated version of the article. Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.

surgery
Erratum to "Additional biomarkers for pathological complete response in triple negative breast cancer"

DOI: https://doi.org/10.1177/17588359241290373

2024-10-21

Abstract:[This corrects the article DOI: 10.1177/17588359241267148.].
Erratum: Author correction to 'VEGFR2-targeted antibody fused with IFNamut regulates the tumor microenvironment of colorectal cancer and exhibits potent anti-tumor and anti-metastasis activity' [Acta Pharm Sin B 11 (2021) 420-433]

Pengzhao Shang,Rui Gao,Yijia Zhu,Xiaorui Zhang,Yang Wang,Minji Guo,Hui Peng,Min Wang,Juan Zhang

DOI: https://doi.org/10.1016/j.apsb.2024.02.014

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2020.09.008.].
Combined Photodynamic and Photothermal Therapy and Immunotherapy for Cancer Treatment: A Review [Corrigendum]

Cunqing Kong,Xingcai Chen

DOI: https://doi.org/10.2147/ijn.s422584

IF: 7.033

2023-05-01

International Journal of Nanomedicine

Abstract:[This corrects the article DOI: 10.2147/IJN.S388996.].

pharmacology & pharmacy,nanoscience & nanotechnology
Erratum: ITGA2 Overexpression Promotes Esophageal Squamous Cell Carcinoma Aggression via FAK/AKT Signaling Pathway [Corrigendum]

DOI: https://doi.org/10.2147/OTT.S390829

2022-09-27

Abstract:[This corrects the article DOI: 10.2147/OTT.S302028.].
Erratum: Protocol of the HISTOTHERM study: assessing the response to hyperthermia and hypofractionated radiotherapy in recurrent breast cancer

Frontiers Production Office

DOI: https://doi.org/10.3389/fonc.2024.1414294

IF: 4.7

2024-04-20

Frontiers in Oncology

Abstract:This article is an erratum on: Protocol of the HISTOTHERM study: assessing the response to hyperthermia and hypofractionated radiotherapy in recurrent breast cancer

oncology
Corrigendum: Neoadjuvant Tislelizumab Combined with Chemotherapy in Locally Advanced Oral or Oropharyngeal Squamous Cell Carcinoma: a Real-World Retrospective Study.

Wen-Jie Wu,Qian Liu,Pu-Gen An,Lin Wang,Jian-Yun Zhang,Yan Chen,Tong Zhang,Jie Zhang

DOI: https://doi.org/10.3389/fimmu.2023.1346845

IF: 7.3

2024-01-01

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2023.1282629.].

Erratum: Thadi A.; et al. Early Investigations and Recent Advances in Intraperitoneal Immunotherapy for Peritoneal Metastasis. Vaccines 2018, 6, 54

Corrigendum to "Long recurrence-free survival of localized rectal melanoma after abdominoperineal resection in comparison to partial excision and highlighting the place of immunotherapy: A case report."

Correction To: Therapeutic Efficacy, Pharmacokinetic Profiles, and Toxicological Activities of Humanized Antibody-Drug Conjugate Zt/g4-MMAE Targeting RON Receptor Tyrosine Kinase for Cancer Therapy

Correction To: Early Presence of Anti-Angiogenesis-related Adverse Events As a Potential Biomarker of Antitumor Efficacy in Metastatic Gastric Cancer Patients Treated with Apatinib: a Cohort Study

Correction: Cao et al. Effective Functional Immunogenicity of a DNA Vaccine Combination Delivered via In Vivo Electroporation Targeting Malaria Infection and Transmission. Vaccines 2022, 10, 1134

Corrigendum: Surgical decision-making following neoadjuvant immunotherapy for dMMR rectal cancer; case reports and review of the literature

Erratum: New insights into the role of macrophages in cancer immunotherapy

Erratum: First step results from a phase II study of a dendritic cell vaccine in glioblastoma patients (CombiG-vax)

Erratum: The efficacy of cancer immunotherapies is compromised by Helicobacter pylori infection

Erratum: Preoperative immunological plasma markers TRAIL, CSF1, and TIE2 predict survival after resection for biliary tract cancer

Corrigendum to: Investigation of the Apoptosis Inducing and β-catenin Silencing by Tetradentate Schiff Base Zinc(II) Complex on the T-47D Breast Cancer Cells

Erratum: "Interferon-γ liposome: a new system to improve drug delivery in the treatment of lung cancer". Maysa Alhawamdeh, Mohammad Isreb, Abid Aziz, Badie K. Jacob, Diana Anderson and Mojgan Najafzadeh. ERJ Open Res 2021; 7: 00555-2020

Corrigendum: Ex vivo modulation of intact tumor fragments with anti-PD-1 and anti-CTLA-4 influences the expansion and specificity of tumor-infiltrating lymphocytes

Erratum to : Introduction to the peripheral T-cell lymphoma review series: advances in molecular characterization, classification refinement and treatment optimization

Erratum to Erratum to relationships between serum levels of vitamins and papillary thyroid cancer: a single center case-control study

Erratum to "Additional biomarkers for pathological complete response in triple negative breast cancer"

Erratum: Author correction to 'VEGFR2-targeted antibody fused with IFNamut regulates the tumor microenvironment of colorectal cancer and exhibits potent anti-tumor and anti-metastasis activity' [Acta Pharm Sin B 11 (2021) 420-433]

Combined Photodynamic and Photothermal Therapy and Immunotherapy for Cancer Treatment: A Review [Corrigendum]

Erratum: ITGA2 Overexpression Promotes Esophageal Squamous Cell Carcinoma Aggression via FAK/AKT Signaling Pathway [Corrigendum]

Erratum: Protocol of the HISTOTHERM study: assessing the response to hyperthermia and hypofractionated radiotherapy in recurrent breast cancer

Corrigendum: Neoadjuvant Tislelizumab Combined with Chemotherapy in Locally Advanced Oral or Oropharyngeal Squamous Cell Carcinoma: a Real-World Retrospective Study.